U.S. Food Stock News

Earlier this week, Loop Capital upgraded Ollie’s Bargain Outlet Holdings to “buy” from “hold,” arguing that the market has underestimated the retailer’s sales potential and competitive strengths. The research call also highlighted how Ollie’s off-price model and merchandising approach may be better positioned than many peers to capture value-focused consumer demand. Next, we’ll examine how Loop Capital’s focus on underestimated sales potential could reshape Ollie’s existing investment...

For investors wondering if Cintas is still worth considering after its big run, or if most of the upside is already priced in, this article will walk through what the numbers are really telling us about the stock's value. The share price has climbed about 2.0% over the last week, 5.0% over the past month, and 5.0% year to date, on top of multi year gains of 74.1% over 3 years and 128.6% over 5 years that indicate the market already sees Cintas as a quality compounder. Recent coverage has...

Innoviva (INVA) just cleared a major hurdle with FDA approval for NUZOLVENCE, a first in class single dose oral antibiotic for uncomplicated gonorrhea, potentially reshaping both its pipeline value and long term growth story. See our latest analysis for Innoviva. The NUZOLVENCE approval lands at a time when Innoviva’s share price has climbed 13.62 percent year to date and 6.46 percent over 90 days, while its 3 year total shareholder return of 51.73 percent signals momentum that investors...

Wondering if WillScot Holdings is quietly turning into a value story after a rough stretch? This breakdown will help you figure out whether the current share price really reflects its long term potential. The stock has inched up about 1.9% over the last week and 10.0% over the past month, even though it is still down roughly 41.4% year to date and 41.6% over the last year. This hints that sentiment might be starting to shift. Recent coverage has focused on how WillScot is repositioning...

Flex (FLEX) has quietly turned into one of the market’s steadier compounders, with the stock up roughly 64% this year and about 3x over the past 3 years. See our latest analysis for Flex. The stock’s 30 day share price return of 11.59 percent on a last close of 63.55 dollars builds on strong year to date momentum. Flex’s three year total shareholder return above 300 percent shows this has been a sustained, rerating story rather than a quick trade. Given that kind of run, it can be worth...

BioCryst Pharmaceuticals previously announced that the FDA approved its New Drug Application for an oral pellet formulation of once-daily ORLADEYO (berotralstat) as the first targeted oral prophylactic therapy for hereditary angioedema in children aged 2 to under 12 years in the U.S. This pediatric-friendly oral option addresses a long-standing gap where younger hereditary angioedema patients relied solely on intravenous or subcutaneous treatments, potentially easing daily treatment burden...

Performance Food Group has announced a leadership succession in which long-time Chairman and CEO George Holm will step down as CEO to become Executive Chair, while current President and COO Scott McPherson will take over as CEO and join the board, with the transition effective January 1, 2026. This handover elevates an executive with deep experience across Performance Food Group’s core segments and prior CEO credentials, while keeping Holm closely involved in acquisitions and overall...

In December 2025, Google Cloud and Palo Alto Networks expanded their partnership to integrate Prisma AIRS across Google’s AI services, including Vertex AI and Agent Engine, and entered a new multibillion-dollar agreement to migrate Palo Alto’s internal security platforms onto Google Cloud’s infrastructure. This deeper alignment aims to build security into every layer of hybrid multicloud AI development, positioning Palo Alto Networks as a core provider of end-to-end protection for...

Earlier this week, Novanta reported a 1.4% year-on-year revenue increase that came in 0.8% above analyst expectations, but EBITDA fell well short of forecasts and marked the slowest revenue growth across its electronic components peers. This mix of stronger-than-expected sales and weaker profitability raises questions about the efficiency of Novanta’s growth engine at a time when peers appear to be scaling more effectively. We’ll now examine how this revenue beat but EBITDA miss may...

Wondering if Bausch + Lomb at around $17 a share is a hidden bargain or a value trap? This article will walk through the numbers in plain English so you can decide for yourself. The stock has inched up 0.8% over the last week and 10.1% across the past month, even though it is still down 5.5% year to date and 4.8% over the last year. This hints that sentiment might be shifting after a tougher stretch. Recent headlines have focused on Bausch + Lomb expanding its eye health portfolio and...

Yalla Group (NYSE:YALA) just caught fresh attention after management bought back 1.49 million shares for about $10.9 million, reflecting a five year stretch of roughly 34% annual earnings growth. See our latest analysis for Yalla Group. Those buybacks come after a powerful run, with the share price now at $7.16 and a strong year to date share price return helping underpin a robust three year total shareholder return. This suggests positive momentum rather than a fading story. If Yalla's...

If you are wondering whether Kyndryl Holdings at around $27 a share still offers value after a big multi year rebound, you are not alone. This breakdown is designed to cut through the noise for you. The stock is up 1.9% over the last week and 11.9% over the last month, but it is still down 23.2% year to date and 22.0% over the past year, even after a striking 157.8% gain over three years. Recent headlines have focused on Kyndryl deepening its cloud and AI partnerships and winning large scale...

Earlier this month, CubeSmart announced that its Board of Trustees declared a quarterly dividend of US$0.53 per common share for the period ending December 31, 2025, payable on January 16, 2026 to shareholders of record as of January 2, 2026. This higher quarterly payout underlines CubeSmart’s emphasis on returning cash to investors, which can be especially relevant for income‑focused REIT shareholders assessing the reliability of future distributions. Next, we’ll explore how this higher...

Wondering if Sezzle at $73.64 is still a smart buy or if the easy gains are gone? You are not alone, and that is exactly what we are going to unpack here. The stock has climbed 5.0% over the last week, 37.8% in the last 30 days, and is up 62.0% year to date, with a 72.8% gain over the past year shifting how the market is thinking about its risk and reward profile. These moves have come alongside growing attention on buy now, pay later players as regulators and investors reassess the space,...

If you are wondering whether Zebra Technologies is starting to look like a bargain again after a rough stretch, you are not alone. This is exactly the kind of stock where valuation work can really pay off. The share price is down 3.3% over the last week and 1.4% over the last month, but the bigger story is the steep slide of 35.9% year to date and 37.8% over the past year, which has reset expectations and risk perceptions in a significant way. Investors have been digesting a mix of macro...

Virtus Investment Partners has just rolled out the Virtus Silvant Growth Opportunities ETF, its 26th ETF, extending the firm’s actively managed lineup and signaling ongoing conviction in growth focused, research driven strategies. See our latest analysis for Virtus Investment Partners. The launch of VGRO comes as Virtus shares trade at $166.56, with a solid 1 month share price return of about 7 percent but a weak year to date share price return of roughly minus 24 percent. The 3 year total...

Open Text (OTEX) has drifted slightly over the past month, but the longer term picture is more interesting. The stock is up about 24% over the past year despite a weaker past 3 months. See our latest analysis for Open Text. That mix of a solid year to date share price return, while the last quarter has slipped back, suggests momentum has cooled a bit as investors reassess growth and integration risks, even though the one year total shareholder return remains comfortably positive. If Open Text...

Kimberly-Clark Corporation has announced it will release its fiscal fourth-quarter earnings before the market opens on January 27, 2026, with analysts forecasting a small year-over-year profit decline. Despite this expected dip, the company has matched or beaten Wall Street earnings estimates in each of the last four quarters, heightening interest in whether that pattern can continue. With analysts projecting a slight earnings pullback, we’ll now examine how this upcoming report could...

Levi Strauss (LEVI) is back on investors radar after two developments landed almost at once: fresh Outperform coverage from Raymond James and the upcoming board appointment of veteran executive Jeffrey J. Jones II. See our latest analysis for Levi Strauss. At around $21.18 per share, Levi’s recent 1 day and year to date share price gains sit against a still solid 1 year total shareholder return of about 25 percent. This suggests momentum has cooled a bit rather than reversed, as investors...

Global Net Lease, Inc. recently declared quarterly dividends on its Series A, B, D, and E preferred stocks, payable on January 15, 2026 to holders of record as of January 2, 2026. The company also closed the sale of the McLaren Campus in Woking, England for £250,000,000, realizing an approximately £80,000,000 gain and reinforcing its capital recycling and balance sheet strengthening efforts. We’ll now examine how this sizeable McLaren Campus sale, with its balance sheet impact, could...

Coty Inc. recently announced that Procter & Gamble veteran Markus Strobel will become Interim CEO and Executive Chairman on January 1, 2026, succeeding outgoing CEO Sue Nabi and long-time Executive Chair Peter Harf after their multi-year tenures. The leadership reshuffle comes as Coty completes the sale of its remaining Wella stake to KKR for US$750,000,000 and confronts pressure on its consumer beauty operations, prompting a broad strategic review. We’ll now examine how Strobel’s dual role...

How Has Deere's Share Price Been Performing? After a strong multi year run, Deere's share price has been more range bound recently, which can make it harder for investors to judge whether the current level really offers good value. To set the scene for a valuation deep dive, it helps to look at how the stock has actually been behaving. Over the last year, Deere has delivered a total return of 9.5%, with shares up 11.8% year to date despite some recent softness. In the shorter term, the stock...

Ultra Clean Holdings (UCTT) just picked up a Zacks Rank #2 (Buy) upgrade after analysts raised their earnings estimates, which is a clear signal that expectations for the company’s near term profit trajectory are improving. See our latest analysis for Ultra Clean Holdings. The upgrade lands after a choppy stretch, with the share price at 26.18 dollars and a 30 day share price return of 13.58 percent contrasting with a weaker year to date share price return and similarly negative one year...

How does Krystal Biotech look on traditional valuation checks To get a clearer handle on whether Krystal Biotech still offers value after such a strong run, it helps to strip things back to the fundamentals and run through a few well known valuation lenses. Here we will walk through how the stock stacks up on simple metrics like price to earnings, price to sales, and price to book, then layer in expectations of future growth to see if the current share price can be justified. Starting with...